JAZZ Jazz Pharmaceuticals plc

Price (delayed)

$254.28

Market cap

$16.51B

P/E Ratio

16.66

Dividend/share

N/A

EPS

$15.26

Enterprise value

$19.28B

?
Relative Growth: Rel. Growth: 75
Relative Strength: Rel. Strength: 85
Relative Valuation: Rel. Valuation: 84
Relative Profitability: Rel. Profitability: 97

Jazz Pharmaceuticals plc is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for ...

Highlights
Jazz Pharmaceuticals's equity has increased by 30% YoY and by 6% from the previous quarter
The company's debt fell by 19% YoY and by 19% QoQ
Jazz Pharmaceuticals's quick ratio has increased by 20% YoY but it has decreased by 16% from the previous quarter

Key stats

What are the main financial stats of JAZZ

JAZZ stock price

How has the Jazz Pharmaceuticals stock price performed over time
Intraday
2.24%
1 week
3.8%
1 month
0.02%
1 year
110.97%
YTD
49.58%
QTD
5.52%

Financial performance

How have Jazz Pharmaceuticals's revenue and profit performed over time
Revenue
$4.6B
Gross profit
$4.07B
Operating income
$896.84M
Net income
$940.76M
Gross margin
88.4%
Net margin
20.4%
The revenue has grown by 13% YoY and by 3.7% from the previous quarter
The gross profit has grown by 12% YoY and by 4.2% from the previous quarter

Price vs fundamentals

How does JAZZ's price correlate with its fundamentals

Growth

What is Jazz Pharmaceuticals's growth rate over time

Valuation

What is Jazz Pharmaceuticals stock price valuation
P/E
16.66
P/B
3.32
P/S
3.49
EV/EBIT
21.46
EV/EBITDA
11.93
EV/Sales
4.19
The price to book (P/B) is 44% higher than the 5-year quarterly average of 2.3 and 33% higher than the last 4 quarters average of 2.5
Jazz Pharmaceuticals's equity has increased by 30% YoY and by 6% from the previous quarter
The price to sales (P/S) is 52% more than the 5-year quarterly average of 2.3 and 34% more than the last 4 quarters average of 2.6
The revenue has grown by 13% YoY and by 3.7% from the previous quarter

Efficiency

How efficient is Jazz Pharmaceuticals business performance

Dividends

What is JAZZ's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for JAZZ.

Financial health

How did Jazz Pharmaceuticals financials performed over time
The total assets is 76% greater than the total liabilities
Jazz Pharmaceuticals's quick ratio has increased by 20% YoY but it has decreased by 16% from the previous quarter
JAZZ's total liabilities is down by 14% since the previous quarter and by 13% year-on-year
The company's debt is 8% lower than its equity
Jazz Pharmaceuticals's debt to equity has decreased by 37% YoY and by 23% QoQ
Jazz Pharmaceuticals's equity has increased by 30% YoY and by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.